Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Aug;10(4):279-87.
doi: 10.1007/s11916-006-0033-z.

Management of chemotherapy-induced peripheral neuropathy

Mark Stillman  1 , Juan P Cata
Affiliations
Review

Management of chemotherapy-induced peripheral neuropathy

Mark Stillman et al. Curr Pain Headache Rep. 2006 Aug.

Abstract

Recent advances in the development and administration of chemotherapy for malignant diseases have been rewarded with prolonged survival rates. The cost of progress has come at a price and the nervous system is frequently the target of chemotherapy-induced neurotoxicity. Unlike more immediate toxicities that effect the gastrointestinal tract and bone marrow, chemotherapy-induced neurotoxicity is frequently delayed in onset and may progress over time. In the peripheral nervous system, the major brunt of the toxicity is directed against the peripheral nerve, resulting in chemotherapy-induced peripheral neuropathy (CIPN). Chemotherapeutic agents used to treat hematologic and solid tumors target a variety of structures and functions in the peripheral nervous system, including the neuronal cell body, the axonal transport system, the myelin sheath, and glial support structures. Each agent exhibits a spectrum of toxic effects unique to its mechanism of toxic injury, and recent study in this field has yielded clearer ideas on how to mitigate injury. Combined with the call for a greater recognition of the potentially devastating ramifications of CIPN on quality of life, basic and clinical researchers have begun to investigate therapy to prevent neurotoxic injury. Preliminary studies have shown promise for some agents including glutamine, glutathione, vitamin E, acetyl-L-carnitine, calcium, and magnesium infusions, but final recommendations await prospective confirmatory studies.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clin Oncol (R Coll Radiol). 2005 Jun;17(4):271-6 - PubMed
    1. Eur J Cancer. 2005 Aug;41(12):1746-50 - PubMed
    1. Neurology. 1995 Oct;45(10):1848-55 - PubMed
    1. Ann Oncol. 2000 May;11(5):509-13 - PubMed
    1. Curr Oncol Rep. 2005 May;7(3):159-60 - PubMed

MeSH terms

Substances

LinkOut - more resources